{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:22:11Z","timestamp":1791044531610,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.dld.2008.05.008","type":"journal-article","created":{"date-parts":[[2008,7,7]],"date-time":"2008-07-07T20:19:23Z","timestamp":1215461963000},"page":"56-66","source":"Crossref","is-referenced-by-count":185,"title":["Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease"],"prefix":"10.1016","volume":"41","author":[{"given":"J.P.","family":"Gisbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.G.","family":"McNicholl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.dld.2008.05.008_bib1","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/gut.2005.081950a","article-title":"European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis","volume":"55","author":"Stange","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.05.008_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cca.2007.02.025","article-title":"Enzymes in feces: useful markers of chronic inflammatory bowel disease","volume":"381","author":"Angriman","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.dld.2008.05.008_bib3","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/00054725-200606000-00013","article-title":"Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease","volume":"12","author":"Konikoff","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2008.05.008_bib4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2036.2006.03184.x","article-title":"Review article: biological activity markers in inflammatory bowel disease","volume":"25","author":"Desai","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2008.05.008_bib5","first-page":"117","article-title":"Role of biological markers in inflammatory bowel disease","volume":"30","author":"Gisbert","year":"2007","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2008.05.008_bib6","first-page":"359","article-title":"Established and emerging biological activity markers of inflammatory bowel disease","volume":"95","author":"Nielsen","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2008.05.008_bib7","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/gut.2005.069476","article-title":"Laboratory markers in IBD: useful, magic, or unnecessary toys?","volume":"55","author":"Vermeire","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.05.008_bib8","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1157\/13046597","article-title":"The role of anti-neutrophil cytoplasmic antibodies (ANCA) and anti-Saccharomyces cerevisiae antibodies (ASCA) in inflammatory bowel disease","volume":"26","author":"Gisbert","year":"2003","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2008.05.008_bib9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/003655299750025624","article-title":"Faecal parameters in the assessment of activity in inflammatory bowel disease","volume":"230","author":"van der Sluys Veer","year":"1999","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.dld.2008.05.008_bib10","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/00054725-200409000-00026","article-title":"C-reactive protein as a marker for inflammatory bowel disease","volume":"10","author":"Vermeire","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2008.05.008_bib11","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ncpgasthep0359","article-title":"The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases","volume":"2","author":"Vermeire","year":"2005","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2008.05.008_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1358\/dot.2001.37.2.614846","article-title":"Fecal calprotectin as an index of intestinal inflammation","volume":"37","author":"Tibble","year":"2001","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.dld.2008.05.008_bib13","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1046\/j.1365-2036.2002.01196.x","article-title":"Review article: faecal markers in the assessment of activity in inflammatory bowel disease","volume":"16","author":"Poullis","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2008.05.008_bib14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/ncpgasthep0094","article-title":"Technology insight: calprotectin, lactoferrin and nitric oxide as novel markers of inflammatory bowel disease","volume":"2","author":"Lundberg","year":"2005","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2008.05.008_bib15","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1136\/gut.34.10.1357","article-title":"Distribution of macrophages and granulocytes expressing L1 protein (calprotectin) in human Peyer's patches compared with normal ileal lamina propria and mesenteric lymph nodes","volume":"34","author":"Bjerke","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.05.008_bib16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/00365529950172835","article-title":"Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease","volume":"34","author":"Roseth","year":"1999","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2008.05.008_bib17","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/gut.47.4.506","article-title":"A simple method for assessing intestinal inflammation in Crohn's disease","volume":"47","author":"Tibble","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.05.008_bib18","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3748\/wjg.v7.i4.460","article-title":"Non-invasive investigation of inflammatory bowel disease","volume":"7","author":"Tibble","year":"2001","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2008.05.008_bib19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/qjmed\/hci069","article-title":"Faecal calprotectin in the assessment of Crohn's disease activity","volume":"98","author":"Gaya","year":"2005","journal-title":"Quart J Med"},{"key":"10.1016\/j.dld.2008.05.008_bib20","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1053\/gast.2002.34755","article-title":"Use of surrogate markers of inflammation and Rome criteria to distinguish organic from non-organic intestinal disease","volume":"123","author":"Tibble","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.05.008_bib21","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3109\/00365529209011186","article-title":"Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study","volume":"27","author":"Roseth","year":"1992","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2008.05.008_bib22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/00365529609006407","article-title":"Faecal calprotectin shedding after short-term treatment with non-steroidal anti-inflammatory drugs","volume":"31","author":"Meling","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2008.05.008_bib23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/gut.45.3.362","article-title":"High prevalence of NSAID enteropathy as shown by a simple faecal test","volume":"45","author":"Tibble","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.05.008_bib24","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1373\/49.6.861","article-title":"Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children","volume":"49","author":"Carroccio","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.dld.2008.05.008_bib25","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.dld.2004.02.009","article-title":"Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice","volume":"36","author":"Berni Canani","year":"2004","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2008.05.008_bib26","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00042737-200305000-00021","article-title":"Proton pump inhibitors are associated with elevation of faecal calprotectin and may affect specificity","volume":"15","author":"Poullis","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2008.05.008_bib27","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1158\/1055-9965.EPI-03-0160","article-title":"Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk","volume":"13","author":"Poullis","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.dld.2008.05.008_bib28","first-page":"41","article-title":"Diagnostic value of fecal calprotectin in predicting an abnormal colonoscopy","volume":"127","author":"Garcia Sanchez Mdel","year":"2006","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.dld.2008.05.008_bib29","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/00005176-200310000-00013","article-title":"Fecal calprotectin levels in healthy children studied with an improved assay","volume":"37","author":"Fagerberg","year":"2003","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2008.05.008_bib30","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3109\/00365529309098312","article-title":"Faecal calprotectin: a novel test for the diagnosis of colorectal cancer?","volume":"28","author":"Roseth","year":"1993","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2008.05.008_bib31","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0161-6420(96)30574-5","article-title":"The effects of multiple doses of ivermectin on ocular onchocerciasis. A six-year follow-up","volume":"103","author":"Mabey","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.dld.2008.05.008_bib32","first-page":"2683","article-title":"Biological variability of fecal calprotectin in patients referred for colonoscopy without colonic inflammation or neoplasm","volume":"96","author":"Husebye","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2008.05.008_bib33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/01.mpg.0000187818.76954.9a","article-title":"Combined use of non-invasive tests is useful in the initial diagnostic approach to a child with suspected inflammatory bowel disease","volume":"42","author":"Canani","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2008.05.008_bib34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00005176-200107000-00003","article-title":"Fecal calprotectin: validation as a non-invasive measure of bowel inflammation in childhood inflammatory bowel disease","volume":"33","author":"Bunn","year":"2001","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2008.05.008_bib35","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S1590-8658(03)00381-5","article-title":"Role of faecal calprotectin as non-invasive marker of intestinal inflammation","volume":"35","author":"Costa","year":"2003","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2008.05.008_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/ibd.20214","article-title":"Fecal M2-pyruvate kinase (M2-PK): a novel marker of intestinal inflammation","author":"Chung-Faye","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2008.05.008_bib37","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00384-006-0159-9","article-title":"Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease","volume":"22","author":"D\u2019Inca","year":"2007","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.dld.2008.05.008_bib38","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2036.2004.02128.x","article-title":"Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology","volume":"20","author":"Dolwani","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2008.05.008_bib39","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/01.MPG.0000154657.08994.94","article-title":"Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms","volume":"40","author":"Fagerberg","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2008.05.008_bib40","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1111\/j.1572-0241.2000.03194.x","article-title":"Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy","volume":"95","author":"Limburg","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2008.05.008_bib41","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1136\/gut.49.3.402","article-title":"Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma","volume":"49","author":"Tibble","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.05.008_bib42","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1572-0241.2007.01556.x","article-title":"Non-invasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices","volume":"103","author":"Langhorst","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2008.05.008_bib43","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1590-8658(03)00375-X","article-title":"Determination of faecal calprotectin, a novel marker of organic gastrointestinal disorders","volume":"35","author":"Roseth","year":"2003","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2008.05.008_bib44","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1080\/08035250500254639","article-title":"Faecal calprotectin in children with chronic gastrointestinal symptoms","volume":"94","author":"Bremner","year":"2005","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.dld.2008.05.008_bib45","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00005176-200102000-00015","article-title":"Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease","volume":"32","author":"Bunn","year":"2001","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2008.05.008_bib46","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/gut.2004.043406","article-title":"Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease","volume":"54","author":"Costa","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.05.008_bib47","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/ibd.20178","article-title":"Assessment of endoscopic activity index and biological inflammatory markers in clinically active Crohn's disease with normal C-reactive protein serum level","volume":"13","author":"Denis","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2008.05.008_bib48","doi-asserted-by":"crossref","DOI":"10.1136\/gut.2006.113431","article-title":"Fecal S100A12 as non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome","author":"Kaiser","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.05.008_bib49","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/01.MIB.0000187980.08686.18","article-title":"Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis","volume":"11","author":"Langhorst","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2008.05.008_bib50","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00005176-200401000-00025","article-title":"Fecal calprotectin in healthy term and preterm infants","volume":"38","author":"Nissen","year":"2004","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2008.05.008_bib51","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1651-2227.2002.tb01638.x","article-title":"Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children","volume":"91","author":"Olafsdottir","year":"2002","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.dld.2008.05.008_bib52","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000201441","article-title":"Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein","volume":"58","author":"Roseth","year":"1997","journal-title":"Digestion"},{"key":"10.1016\/j.dld.2008.05.008_bib53","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1080\/00365520410007971","article-title":"Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease","volume":"39","author":"Roseth","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2008.05.008_bib54","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/00042737-200208000-00005","article-title":"Faecal calprotectin: a marker of inflammation throughout the intestinal tract","volume":"14","author":"Summerton","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2008.05.008_bib55","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0016-5085(03)00383-4","article-title":"Subclinical intestinal inflammation: an inherited abnormality in Crohn's disease relatives?","volume":"124","author":"Thjodleifsson","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.05.008_bib56","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/gast.2000.8523","article-title":"Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease","volume":"119","author":"Tibble","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.05.008_bib57","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1258\/000456304323019613","article-title":"Faecal calprotectin: a new marker for Crohn's disease?","volume":"41","author":"Wassell","year":"2004","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.dld.2008.05.008_bib58","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1365-2036.2007.03457.x","article-title":"Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin","volume":"26","author":"Schroder","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2008.05.008_bib59","first-page":"117","article-title":"Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome","volume":"51","author":"Silberer","year":"2005","journal-title":"Clin Lab"},{"key":"10.1016\/j.dld.2008.05.008_bib60","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1572-0241.2007.01126.x","article-title":"Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy","volume":"102","author":"von Roon","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2008.05.008_bib61","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/00042737-200208000-00002","article-title":"Faecal calprotectin: a marker of inflammation throughout the intestinal tract","volume":"14","author":"Aadland","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2008.05.008_bib62","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1111\/j.1572-0241.2006.00840.x","article-title":"Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease","volume":"101","author":"Reese","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2008.05.008_bib63","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0009-8981(99)00206-5","article-title":"Improved assay for fecal calprotectin","volume":"292","author":"Ton","year":"2000","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.dld.2008.05.008_bib64","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/qjmed\/95.9.557","article-title":"Faecal calprotectin: a bright future for assessing disease activity in Crohn's disease","volume":"95","author":"Gaya","year":"2002","journal-title":"Quart J Med"},{"key":"10.1016\/j.dld.2008.05.008_bib65","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1023\/B:DDAS.0000042243.47279.87","article-title":"Relationship between fecal calprotectin, intestinal inflammation, and peripheral blood neutrophils in patients with active ulcerative colitis","volume":"49","author":"Hanai","year":"2004","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2008.05.008_bib66","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1080\/00365520500419623","article-title":"Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease","volume":"41","author":"Kolho","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2008.05.008_bib67","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ibd.20042","article-title":"Fecal excretion of deoxyribonucleic acid in long-term follow-up of patients with inactive ulcerative colitis","volume":"13","author":"Casellas","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2008.05.008_bib68","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1572-0241.2003.07458.x","article-title":"Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation","volume":"98","author":"Kane","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2008.05.008_bib69","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1572-0241.2006.00884.x","article-title":"Fecal calprotectin in first-degree relatives of patients with ulcerative colitis","volume":"102","author":"Montalto","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2008.05.008_bib70","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000199277","article-title":"Clinical remission in Crohn's disease\u2014assessment using faecal 111In granulocyte excretion","volume":"33","author":"Saverymuttu","year":"1986","journal-title":"Digestion"},{"key":"10.1016\/j.dld.2008.05.008_bib71","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/gut.2004.048850","article-title":"Predicting relapse in patients with inflammatory bowel disease: what is the role of biomarkers?","volume":"54","author":"Pardi","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.05.008_bib72","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s10350-007-0225-6","article-title":"Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease","volume":"50","author":"Scarpa","year":"2007","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.dld.2008.05.008_bib73","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1007\/s10620-004-9562-7","article-title":"The role of costimulatory molecules CD80 and CD86 and IFNgamma in the pathogenesis of ulcerative colitis","volume":"49","author":"Scarpa","year":"2004","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2008.05.008_bib74","first-page":"S53","article-title":"Endoscopic management of inflammatory bowel disease","volume":"89","author":"Modigliani","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2008.05.008_bib75","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0016-5085(90)90002-I","article-title":"Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d\u2019Etude Therapeutique des Affections Inflammatoires Digestives","volume":"98","author":"Modigliani","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.05.008_bib76","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1046\/j.1365-2036.2002.01242.x","article-title":"Review article: is clinical remission the optimum therapeutic goal in the treatment of Crohn's disease?","volume":"16","author":"Arnott","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2008.05.008_bib77","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0016-5107(04)01878-4","article-title":"Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD","volume":"60","author":"Daperno","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.dld.2008.05.008_bib78","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/bjs.1800780106","article-title":"Recurrence of Crohn's disease after resection","volume":"78","author":"Williams","year":"1991","journal-title":"Br J Surg"},{"key":"10.1016\/j.dld.2008.05.008_bib79","first-page":"17","article-title":"The role of calprotectin in predicting endoscopic post-surgical recurrence in asymptomatic Crohn's disease: a comparison with ultrasound","volume":"10","author":"Orlando","year":"2006","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865808001916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865808001916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T10:58:58Z","timestamp":1545908338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865808001916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S1590865808001916"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2008.05.008","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}